131 related articles for article (PubMed ID: 3593991)
21. Antiestrogen binding within different pituitary cell populations. Comparison with androgen and estrogen receptors.
Thieulant ML; Adelaide J; Duval J
J Steroid Biochem; 1986 Jan; 24(1):395-9. PubMed ID: 3702423
[TBL] [Abstract][Full Text] [Related]
22. Improved measurement of androgen receptors in human breast cancer.
Lea OA; Kvinnsland S; Thorsen T
Cancer Res; 1989 Dec; 49(24 Pt 1):7162-7. PubMed ID: 2582456
[TBL] [Abstract][Full Text] [Related]
23. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer.
Calandra RS; Charreau EH; Royer de Giaroli M; Baldi A
Prog Clin Biol Res; 1984; 142():97-108. PubMed ID: 6709661
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS).
Poirot M; De Medina P; Delarue F; Perie JJ; Klaebe A; Faye JC
Bioorg Med Chem; 2000 Aug; 8(8):2007-16. PubMed ID: 11003145
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
Macías A; Pascual MR; Pérez R; Lage A
Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of estrogen receptor, antiestrogen binding sites and calmodulin for antiestrogen resistance of two clones derived from the MCF-7 breast cancer cell line.
Borras M; Jin L; Bouhoute A; Legros N; Leclercq G
Biochem Pharmacol; 1994 Nov; 48(11):2015-24. PubMed ID: 7802690
[TBL] [Abstract][Full Text] [Related]
27. Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages--immunohistochemical study of 107 cases.
Jacquemier JD; Hassoun J; Torrente M; Martin PM
Breast Cancer Res Treat; 1990 Feb; 15(2):109-17. PubMed ID: 2322649
[TBL] [Abstract][Full Text] [Related]
28. Influence of endocrine status on biochemical and immunocytochemical estrogen and progesterone receptor assays in breast cancer patients.
Helin HJ; Isola JJ; Helle MJ; Adlercreutz H
Breast Cancer Res Treat; 1988 Sep; 12(1):67-73. PubMed ID: 3196886
[TBL] [Abstract][Full Text] [Related]
29. Estradiol and progesterone receptor levels in human breast cancer in relation to cytosol and plasma estrogen level.
Drafta D; Prişcu A; Neacşu E; Gangură M; Schindler AE; Stroe E; Anghel C; Panaitescu G
J Steroid Biochem; 1983 Apr; 18(4):459-63. PubMed ID: 6834830
[TBL] [Abstract][Full Text] [Related]
30. Lactate dehydrogenase in breast carcinoma: correlation with estrogen and progesterone receptors.
Brentani MM; Nagai MA
Cancer Detect Prev; 1983; 6(1-2):241-7. PubMed ID: 6883383
[TBL] [Abstract][Full Text] [Related]
31. Modifications of benzylphenoxy ethanamine antiestrogen molecules: influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity.
Delarue F; Kedjouar B; Mésange F; Bayard F; Faye JC; Poirot M
Biochem Pharmacol; 1999 Mar; 57(6):657-61. PubMed ID: 10037451
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site.
Murphy LC; Sutherland RL
J Clin Endocrinol Metab; 1983 Aug; 57(2):373-9. PubMed ID: 6408114
[TBL] [Abstract][Full Text] [Related]
33. Clinical and experimental aspects of hormone receptors in breast carcinoma patients.
Spona J; Kolb R; Reiner G; Jakesz R; Moser K; Rainer H
Cancer Detect Prev; 1983; 6(1-2):227-34. PubMed ID: 6883382
[TBL] [Abstract][Full Text] [Related]
34. [Factors affecting estrogen and progesterone receptors in primary breast cancer].
Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K
Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical versus biochemical estrogen-receptor and progesterone-receptor analysis: correlation with histological parameters.
Helle M; Helin M; Isola J; Helin H
J Cancer Res Clin Oncol; 1989; 115(4):361-5. PubMed ID: 2760100
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of estrogen and progesterone receptors in stage II breast cancer.
Rydén S; Fernö M; Borg A; Hafström L; Möller T; Norgren A
J Surg Oncol; 1988 Apr; 37(4):221-6. PubMed ID: 3283457
[TBL] [Abstract][Full Text] [Related]
37. Steroid hormone receptors and sex chromatin frequency in breast cancer.
Smethurst M; Bishun NP; Fernandez D; Allen J; Burn JI; Alaghband-Zadeh J; Williams DC
J Endocrinol Invest; 1981; 4(4):455-7. PubMed ID: 7334186
[TBL] [Abstract][Full Text] [Related]
38. Estrogen and progesterone receptors in human breast cancer with concomitant assay of plasma 17beta-estradiol, progesterone, and prolactin levels.
Nagai R; Kataoka M; Kobayashi S; Ishihara K; Tobioka N; Nakashima K; Naruse M; Saito K; Sakuma S
Cancer Res; 1979 May; 39(5):1834-40. PubMed ID: 427816
[TBL] [Abstract][Full Text] [Related]
39. Displacement by tamoxifen of the estradiol-estrogen receptor binding: a functional assay for breast cancer studies.
Levin E; Tomchinsky S; López S
J Steroid Biochem Mol Biol; 1990 Dec; 37(5):681-6. PubMed ID: 2278851
[TBL] [Abstract][Full Text] [Related]
40. Subcellular concentrations of estrone, estradiol, androstenedione and 17 beta-hydroxysteroid dehydrogenase (17-beta-OH-SDH) activity in malignant and non-malignant human breast tissues.
Mehta RR; Valcourt L; Graves J; Green R; Das Gupta TK
Int J Cancer; 1987 Sep; 40(3):305-8. PubMed ID: 3040598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
